These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 29131264)
1. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer. Huang HW; Xie H; Ma X; Zhao F; Gao Y Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4529-4535. PubMed ID: 29131264 [TBL] [Abstract][Full Text] [Related]
2. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway. Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients. Chen X; Liu L; Zhu W Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527 [TBL] [Abstract][Full Text] [Related]
4. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer. Cao S; Liu W; Li F; Zhao W; Qin C Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758 [TBL] [Abstract][Full Text] [Related]
5. LncRNA CASC9 promotes tumorigenesis by affecting EMT and predicts poor prognosis in esophageal squamous cell cancer. Gao GD; Liu XY; Lin Y; Liu HF; Zhang GJ Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):422-429. PubMed ID: 29424900 [TBL] [Abstract][Full Text] [Related]
6. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients. Li X; Wang F; Sun Y; Fan Q; Cui G Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer. Cao W; Peng T; Zhou Y J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of LncRNA PANDAR predicts a poor prognosis in gastric cancer. Ma P; Xu T; Huang M; Shu Y Biomed Pharmacother; 2016 Mar; 78():172-176. PubMed ID: 26898439 [TBL] [Abstract][Full Text] [Related]
9. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma. Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer. Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer. Liu J; Ben Q; Lu E; He X; Yang X; Ma J; Zhang W; Wang Z; Liu T; Zhang J; Wang H Cell Death Dis; 2018 Feb; 9(2):168. PubMed ID: 29416011 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer. Li Y; Su X; Pan H Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011 [TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway. Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155 [TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of long-non-coding RNA GHET1 in pancreatic cancer. Zhou HY; Zhu H; Wu XY; Chen XD; Qiao ZG; Ling X; Yao XM; Tang JH Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5081-5088. PubMed ID: 29228419 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway. Liu CN; Zhang HY; Liu CL; Wang CC Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer. Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M Arch Gynecol Obstet; 2014 Oct; 290(4):717-23. PubMed ID: 24748337 [TBL] [Abstract][Full Text] [Related]
17. Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer. Zhao LP; Li RH; Han DM; Zhang XQ; Nian GX; Wu MX; Feng Y; Zhang L; Sun ZG Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5353-5360. PubMed ID: 29243775 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer. Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma. Peng W; Fan H Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684 [TBL] [Abstract][Full Text] [Related]
20. Low expression of long noncoding XLOC_010588 indicates a poor prognosis and promotes proliferation through upregulation of c-Myc in cervical cancer. Liao LM; Sun XY; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M; Huang L Gynecol Oncol; 2014 Jun; 133(3):616-23. PubMed ID: 24667250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]